Expert Meeting GLP-1, CVD & T2DM
Report of a meeting with 16 leading European experts in the field of diabetes & CVD discussing the role of novel diabetes drugs in the management of CVD
Episodes 1-5 of 5
- Expert Meeting GLP-1, CVD & T2DMNovel diabetes drugs in clinical management: Extending the opportunities
- Expert Meeting GLP-1, CVD & T2DMWhat are the key mechanisms of CV benefit of novel diabetes drugs?
- Expert Meeting GLP-1, CVD & T2DMClinical trials in diabetes and CVD: What did we learn?
- Expert Meeting GLP-1, CVD & T2DMWhat is the science driving CVD and T2DM?
- Expert Meeting GLP-1, CVD & T2DMTranslation of novel approaches in CVD & diabetes to clinical practice